179 related articles for article (PubMed ID: 6231069)
1. Defective binding of the third component of complement (C3) to Streptococcus pneumoniae in multiple myeloma.
Cheson BD; Walker HS; Heath ME; Gobel RJ; Janatova J
Blood; 1984 Apr; 63(4):949-57. PubMed ID: 6231069
[TBL] [Abstract][Full Text] [Related]
2. Defective complement activity in chronic lymphocytic leukemia.
Heath ME; Cheson BD
Am J Hematol; 1985 May; 19(1):63-73. PubMed ID: 3845763
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein inhibits pneumococcal activation of the alternative pathway by increasing the interaction between factor H and C3b.
Mold C; Kingzette M; Gewurz H
J Immunol; 1984 Aug; 133(2):882-5. PubMed ID: 6234363
[TBL] [Abstract][Full Text] [Related]
4. Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathway.
Yuste J; Sen A; Truedsson L; Jönsson G; Tay LS; Hyams C; Baxendale HE; Goldblatt F; Botto M; Brown JS
Infect Immun; 2008 Aug; 76(8):3761-70. PubMed ID: 18541650
[TBL] [Abstract][Full Text] [Related]
5. Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3.
Newman SL; Mikus LK
J Exp Med; 1985 Jun; 161(6):1414-31. PubMed ID: 2409200
[TBL] [Abstract][Full Text] [Related]
6. Streptococcus pneumoniae capsular serotype invasiveness correlates with the degree of factor H binding and opsonization with C3b/iC3b.
Hyams C; Trzcinski K; Camberlein E; Weinberger DM; Chimalapati S; Noursadeghi M; Lipsitch M; Brown JS
Infect Immun; 2013 Jan; 81(1):354-63. PubMed ID: 23147038
[TBL] [Abstract][Full Text] [Related]
7. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
Mayes JT; Schreiber RD; Cooper NR
J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
[TBL] [Abstract][Full Text] [Related]
8. Localization of complement component 3 on Streptococcus pneumoniae: anti-capsular antibody causes complement deposition on the pneumococcal capsule.
Brown EJ; Joiner KA; Cole RM; Berger M
Infect Immun; 1983 Jan; 39(1):403-9. PubMed ID: 6822421
[TBL] [Abstract][Full Text] [Related]
9. Binding of C-reactive protein to the pneumococcal capsule or cell wall results in differential localization of C3 and stimulation of phagocytosis.
Holzer TJ; Edwards KM; Gewurz H; Mold C
J Immunol; 1984 Sep; 133(3):1424-30. PubMed ID: 6747291
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of C3 by a casein kinase released from activated human platelets increases opsonization of immune complexes and binding to complement receptor type 1.
Nilsson-Ekdahl K; Nilsson B
Eur J Immunol; 2001 Apr; 31(4):1047-54. PubMed ID: 11298329
[TBL] [Abstract][Full Text] [Related]
11. Activation, binding, and processing of complement component 3 (C3) by Blastomyces dermatitidis.
Zhang MX; Klein B
Infect Immun; 1997 May; 65(5):1849-55. PubMed ID: 9125571
[TBL] [Abstract][Full Text] [Related]
12. Pleiotropic effects of cell wall amidase LytA on Streptococcus pneumoniae sensitivity to the host immune response.
Ramos-Sevillano E; Urzainqui A; Campuzano S; Moscoso M; González-Camacho F; Domenech M; Rodríguez de Córdoba S; Sánchez-Madrid F; Brown JS; García E; Yuste J
Infect Immun; 2015 Feb; 83(2):591-603. PubMed ID: 25404032
[TBL] [Abstract][Full Text] [Related]
13. Analysis of complement C3 deposition and degradation on Klebsiella pneumoniae.
Albertí S; Alvarez D; Merino S; Casado MT; Vivanco F; Tomás JM; Benedí VJ
Infect Immun; 1996 Nov; 64(11):4726-32. PubMed ID: 8890232
[TBL] [Abstract][Full Text] [Related]
14. C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.
Wåhlin B; Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
J Immunol; 1983 Jun; 130(6):2831-6. PubMed ID: 6222118
[TBL] [Abstract][Full Text] [Related]
15. The biochemistry of opsonization: central role of the reactive thiolester of the third component of complement.
Hostetter MK; Krueger RA; Schmeling DJ
J Infect Dis; 1984 Nov; 150(5):653-61. PubMed ID: 6491376
[TBL] [Abstract][Full Text] [Related]
16. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice.
Brown JS; Hussell T; Gilliland SM; Holden DW; Paton JC; Ehrenstein MR; Walport MJ; Botto M
Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16969-74. PubMed ID: 12477926
[TBL] [Abstract][Full Text] [Related]
17. Biofilm formation avoids complement immunity and phagocytosis of Streptococcus pneumoniae.
Domenech M; Ramos-Sevillano E; García E; Moscoso M; Yuste J
Infect Immun; 2013 Jul; 81(7):2606-15. PubMed ID: 23649097
[TBL] [Abstract][Full Text] [Related]
18. Impaired C3b/iC3b deposition on Streptococcus pneumoniae in serum from patients with systemic lupus erythematosus.
Goldblatt F; Yuste J; Isenberg DA; Rahman A; Brown J
Rheumatology (Oxford); 2009 Dec; 48(12):1498-501. PubMed ID: 19797312
[TBL] [Abstract][Full Text] [Related]
19. Complement abnormalities in multiple myeloma.
Zurlo JJ; Schechter GP; Fries LF
Am J Med; 1989 Oct; 87(4):411-20. PubMed ID: 2679074
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte phagocytosis of Streptococcus pneumoniae in properdin-deficient serum.
Braconier JH; Odeberg H; Sjöholm AG
Infect Immun; 1983 Apr; 40(1):219-24. PubMed ID: 6403465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
